Abstract
The serotonergic system is involved in the pathophysiology of major depression as well as in the early central nervous system development and adult neuroplasticity. The aim of the study was to examine in 77 patients with major depression and 77 healthy controls the association between the triallelic polymorphism in the promoter region of the serotonin transporter gene (5-HTTLPR) and gray matter (GM) brain volumes measured with 1.5 T magnetic resonance imaging. Voxel-based morphometry were estimated on magnetic resonance images and genotyping was performed. We found that healthy controls have a strong association between the 5-HTTLPR and GM volumes of the dorsolateral prefrontal cortex, left anterior gyrus cinguli, left amygdala as well as right hippocampus, whereas there is no such association in patients with major depression. Healthy subjects carrying the S- or LG-allele have smaller GM volumes than those with the LA-allele, indicating that 5-HTTLPR contributes to the development of brain structures. Patients with depression show reduced GM volumes, particularly when they are homozygous for the LA-allele, suggesting that these patients are more vulnerable for morphological changes during depressive episodes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Duman RS . Pathophysiology of depression: the concept of synaptic plasticity. Eur Psychiatry 2002; 17 (Suppl 3): 306–310.
Lauder JM . Neurotransmitters as growth regulatory signals: role of receptors and second messengers. Trends Neurosci 1993; 16: 233–240.
Gould E . Serotonin and hippocampal neurogenesis. Neuropsychopharmacology 1999; 21 (Suppl 2): 46S–51S.
Nibuya M, Morinobu S, Duman RS . Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995; 15: 7539–7547.
Duman RS . Pathophysiology of depression: the concept of synaptic plasticity. Eur Psychiatry 2002; 17 (Suppl 3): 306–310.
Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003; 301: 805–809.
Mossner R, Daniel S, Albert D, Heils A, Okladnova O, Schmitt A et al. Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem Int 2000; 36: 197–202.
Reagan LP, McEwen BS . Controversies surrounding glucocorticoid-mediated cell death in the hippocampus. J Chem Neuroanat 1997; 13: 149–167.
Woolley CS, Gould E, McEwen BS . Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res 1990; 531: 225–231.
Campbell S, Marriott M, Nahmias C, MacQueen GM . Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry 2004; 161: 598–607.
Taki Y, Kinomura S, Awata S, Inoue K, Sato K, Ito H et al. Male elderly subthreshold depression patients have smaller volume of medial part of prefrontal cortex and precentral gyrus compared with age-matched normal subjects: a voxel-based morphometry. J Affect Disord 2005; 88: 313–320.
Bell-McGinty S, Butters MA, Meltzer CC, Greer PJ, Reynolds III CF, Becker JT . Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. Am J Psychiatry 2002; 159: 1424–1427.
Bueller JA, Aftab M, Sen S, Gomez-Hassan D, Burmeister M, Zubieta JK . BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 2006; 59: 812–815.
Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 2004; 24: 10099–100102.
Frodl T, Schule C, Schmitt G, Born C, Baghai T, Zill P et al. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry 2007; 64: 410–416.
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527–1531.
Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A et al. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in serotonin transporter-deficient mice. Mol Pharmacol 1998; 53: 649–655.
Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D et al. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 2000; 47: 643–649.
Frodl T, Meisenzahl EM, Zill P, Baghai T, Rujescu D, Leinsinger G et al. Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch Gen Psychiatry 2004; 61: 177–183.
Taylor WD, Steffens DC, Payne ME, MacFall JR, Marchuk DA, Svenson IK et al. Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression. Arch Gen Psychiatry 2005; 62: 537–544.
Hu X, Oroszi G, Chun J, Smith TL, Goldman D, Schuckit MA . An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 2005; 29: 8–16.
Hamilton M . A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62.
Oldfield RC . The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971; 9: 97–113.
Ashburner J, Friston KJ . Unified segmentation. Neuroimage 2005; 26: 839–851.
Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS . A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001; 14 (1 Part 1): 21–36.
Cuadra MB, Cammoun L, Butz T, Cuisenaire O, Thiran JP . Comparison and validation of tissue modelization and statistical classification methods in T1-weighted MR brain images. IEEE Trans Med Imaging 2005; 24: 1548–1565.
Hu X, Oroszi G, Chun J, Smith TL, Goldman D, Schuckit MA . An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 2005; 29: 8–16.
Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002; 15: 273–289.
Heim C, Nemeroff CB . The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry 2001; 49: 1023–1039.
Taylor WD, Steffens DC, Payne ME, MacFall JR, Marchuk DA, Svenson IK et al. Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression. Arch Gen Psychiatry 2005; 62: 537–544.
Gaspar P, Cases O, Maroteaux L . The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 2003; 4: 1002–1012.
Sikich L, Hickok JM, Todd RD . 5-HT1A receptors control neurite branching during development. Brain Res Dev Brain Res 1990; 56: 269–274.
Gould E . Serotonin and hippocampal neurogenesis. Neuropsychopharmacology 1999; 21 (Suppl 2): 46S–51S.
Mossner R, Daniel S, Albert D, Heils A, Okladnova O, Schmitt A et al. Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem Int 2000; 36: 197–202.
Nibuya M, Morinobu S, Duman RS . Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995; 15: 7539–7547.
Duman RS . Pathophysiology of depression: the concept of synaptic plasticity. Eur Psychiatry 2002; 17 (Suppl 3): 306–310.
Zill P, Padberg F, de JS, Hampel H, Burger K, Stubner S et al. Serotonin transporter (5-HTT) gene polymorphism in psychogeriatric patients. Neurosci Lett 2000; 284: 113–115.
Li T, Holmes C, Sham PC, Vallada H, Birkett J, Kirov G et al. Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease. Neuroreport 1997; 8: 683–686.
Hu M, Retz W, Baader M, Pesold B, Adler G, Henn FA et al. Promoter polymorphism of the 5-HT transporter and Alzheimer's disease. Neurosci Lett 2000; 294: 63–65.
Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386–389.
Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B . The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry 2005; 62: 529–535.
Kaufman J, Yang BZ, Douglas-Palumberi H, Grasso D, Lipschitz D, Houshyar S et al. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry 2006; 59: 673–680.
Zalsman G, Huang YY, Oquendo MA, Burke AK, Hu XZ, Brent DA et al. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry 2006; 163: 1588–1593.
Chorbov VM, Lobos EA, Todorov AA, Heath AC, Botteron KN, Todd RD . Relationship of 5-HTTLPR genotypes and depression risk in the presence of trauma in a female twin sample. Am J Med Genet B Neuropsychiatr Genet 2007; 144: 830–833.
Acknowledgements
This study was supported by the German Federal Research Ministry within the promotion ‘German Research Networks in Medicine’ as part of the project ‘German Research Network on Depression’ and Maike Moergenthaler carried out her doctoral thesis within this study. Moreover, we thank Mrs Jaquie Klesing for native english editing.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Frodl, T., Koutsouleris, N., Bottlender, R. et al. Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression. Mol Psychiatry 13, 1093–1101 (2008). https://doi.org/10.1038/mp.2008.62
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2008.62
Keywords
This article is cited by
-
Integrative omics analysis reveals epigenomic and transcriptomic signatures underlying brain structural deficits in major depressive disorder
Translational Psychiatry (2024)
-
A Systematic Review of the Variation in Pain Catastrophizing Scale Reference Scores Based on Language Version and Country in Patients with Chronic Primary (Non-specific) Pain
Pain and Therapy (2022)
-
Astrocytic GABAB Receptors in Mouse Hippocampus Control Responses to Behavioral Challenges through Astrocytic BDNF
Neuroscience Bulletin (2020)
-
The 5-HTTLPR Polymorphism of the Serotonin Transporter Gene and the Intellectual Environment of Work Activity as Factors Associated with Changes to Memory in Aging
Neuroscience and Behavioral Physiology (2019)
-
Association of Serotonin Transporter Gene AluJb Methylation with Major Depression, Amygdala Responsiveness, 5-HTTLPR/rs25531 Polymorphism, and Stress
Neuropsychopharmacology (2018)